Cargando…
High-dose concurrent chemo–proton therapy for Stage III NSCLC: preliminary results of a Phase II study
The aim of this report is to present the preliminary results of a Phase II study of high-dose (74 Gy RBE) proton beam therapy (PBT) with concurrent chemotherapy for unresectable locally advanced non-small-cell lung cancer (NSCLC). Patients were treated with PBT and chemotherapy with monthly cisplati...
Autores principales: | Oshiro, Yoshiko, Okumura, Toshiyuki, Kurishima, Koichi, Homma, Shinsuke, Mizumoto, Masashi, Ishikawa, Hitoshi, Onizuka, Masataka, Sakai, Mitsuaki, Goto, Yukinobu, Hizawa, Nobuyuki, Sato, Yukio, Sakurai, Hideyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4202292/ https://www.ncbi.nlm.nih.gov/pubmed/24864278 http://dx.doi.org/10.1093/jrr/rru034 |
Ejemplares similares
-
Isolated solitary brain metastasis as a relapse of small cell lung cancer
por: SAKURAI, HIROFUMI, et al.
Publicado: (2013) -
Significance of indocyanine green test in radiotherapy for hepatocellular carcinoma
por: Mizumoto, Masashi, et al.
Publicado: (2019) -
Comparison of dose–volume histograms between proton beam and X-ray conformal radiotherapy for locally advanced non-small-cell lung cancer
por: Ohno, Toshiki, et al.
Publicado: (2015) -
Long‐term outcomes of high‐dose (74 GyE) proton beam therapy with concurrent chemotherapy for stage III nonsmall‐cell lung cancer
por: Ohnishi, Kayoko, et al.
Publicado: (2021) -
Impact of RhoA overexpression on clinical outcomes in cervical squamous cell carcinoma treated with concurrent chemoradiotherapy
por: Tanaka, Keiichi, et al.
Publicado: (2020)